Dr. Patrice "Patrick" Delafontaine
Professor of Medicine/Executive Dean | Tulane University
New Orleans , LA, UNITED STATES
Dr. Patrice “Patrick” Delafontaine is a physician-scientist and COVID-19 expert in interventional cardiology and vascular biology.
Media
Publications:
Documents:
Photos:
Videos:
Audio/Podcasts:
Biography
Dr. Patrice “Patrick” Delafontaine’s research has been continuously funded for over 20 years by the National Institutes of Health. His focus has been growth factors, cellular and molecular biology and atherosclerosis.
His current areas of investigative focus include 1) the Role of IGF I and its Binding Proteins in Vascular Growth and Atherosclerosis; 2) Vascular Smooth Muscle and Endothelial Cell Biology; 3) Unstable Angina and Coronary Atherosclerosis; and 4) Mechanisms of Muscle Wasting in Chronic Disease States.
Dr. Delafontaine has been a member of the Southern Society for Clinical Investigation since 2005, and has served on the Council and Nominating committee. He currently serves on the Mentoring committee and the Speakers Bureau of the Visiting Professor Program of the SSCI.
Dr. Delafontaine has held positions at Emory University, the University of Geneva, the University of Kansas Medical School and Tulane University. During his first tenure at Tulane he was the Vice Chair of Research for the Department of Medicine, Chief of the Section of Cardiology, Director of the Tulane Heart and Vascular Institute and was the Interim Chair of the Department of Medicine. He was also the Director of the NIH funded Louisiana Clinical and Translational Science Center's Clinical Translational Unit at the Tulane University. In December 2014, Dr. Delafontaine was appointed as the Hugh E. and Sarah D. Stephenson Dean at the University of Missouri - Columbia.
Dr. Delafontaine completed his studies and received his Doctorate in Medicine at the University of Geneva in Geneva, Switzerland, and his residency in Internal Medicine at the Hahnemann Medical College and Hospital in Philadelphia, PA. He completed a research and a clinical fellowship program in cardiology at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts.
Areas of Expertise (5)
Physician-Scientist
COVID-10 (Coronavirus)
Cardiology
Interventional Cardiology
Vascular Biology
Accomplishments (12)
A.J. de Cotis Award for Outstanding Medical Resident (professional)
1979
Geneva University Hospital Training Fund Award (professional)
1984
Swiss National Research Fund Award (professional)
1985
American Heart Association - Massachusetts Affiliate Fellowship Award (professional)
1986
American Heart Association - Massachusetts Affiliate Fellowship Award (professional)
1987
Distinguished Achievement Award of the American Heart Association, Georgia Affiliate (professional)
1993
Tinsley Harrison Award of the Southern Society of Clinical Investigation (professional)
1994
Established Investigator Award - American Heart Association (professional)
1994
Research Career Development Award - National Institutes of Health (professional)
1994
Present Elected by his peers for inclusion in Best Doctors in America® (professional)
2001
University of Missouri Columbia International Center for Psychosocial Trauma Annual Humanitarian Award (professional)
2017
Kaley Award Featured Topic: The Microcirculation and Its Many Cells that Contribute to Tissue Repair, (professional)
2019
Education (4)
University of Geneva: MD, Faculty of Medicine
Hahnemann Medical College: Residency, Internal Medcine
Harvard Medical School and Brigham and Women's Hospital: Research and Clinical Fellowship, Cardiology
University of Geneva: BS, Faculty of Sciences and Medicine
Affiliations (3)
- Southern Society for Clinical Investigation
- Speakers Bureau of the Visiting Professor Program of the SSCI
- Louisiana Clinical and Translational Science Center's Clinical Translational Unit
Links (1)
Media Appearances (1)
Tulane School of Medicine launches COVID-19 testing lab to improve capacity
KATC (ABC) Lafayette online
2020-04-03
Tulane University has added a second avenue for COVID-19 testing, this one taking place at a Tulane School of Medicine repurposed research lab where results can be processed within a day.
Social